(thirdQuint)Modufolin in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer.

 The study will investigate the tolerability of Modufolin at four (4) different dose levels (30 to 240 mg/m2) in therapy combinations with the chemotherapeutic agents 5-FU, Oxaliplatin +/- bevcizumab, and Irinotecan.

 When the selected phase 2 dose is determined, 20 additional patients, will be included in the study in order to acquire more data on the safety and tolerability of Modufolin at this dose level.

 Ten (10) of these additional patients will be treated in with Oxaliplatin, 10 with Irinotecan.

.

 Modufolin in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer@highlight

The purpose is to characterise the tolerability of Modufolin in combination with 5-FU alone, in combination with 5-FU and Oxaliplatin, in combination with 5-FU and Irinotecan and in combination with 5-FU, Oxaliplatin and Bevacizumab.

 Another purpose is to investigate 4 doses of Modufolin to identify the best dose for further assessment.

